Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02558192
Other study ID # IN001
Secondary ID
Status Completed
Phase Phase 3
First received April 13, 2015
Last updated September 22, 2015
Start date January 2014
Est. completion date June 2015

Study information

Verified date September 2015
Source Federico II University
Contact n/a
Is FDA regulated No
Health authority Italy: The Italian Medicines Agency
Study type Interventional

Clinical Trial Summary

Nosocomial infections are infections that occur from the time of 'entry in the hospital up to 48h after discharge. In most developed countries, the incidence of nosocomial infections in children is between 5% and 44% with the predominance of respiratory infections and gastrointestinal infections. Nosocomial infections prolong the time of hospital stay, reduce the effectiveness of treatment, significantly increasing hospital costs. Current measures for prevention of nosocomial infections in pediatrics, such as vaccinations and compliance with sanitary regulations, are not fully effective. Therefore it is necessary a deepening of the possible methods of prevention, between which has been already tested the use of probiotics such as Lactobacillus GG. A recent RCCT, which provided for the administration of LGG against placebo, noted a significant reduction in the risk of gastrointestinal infections and respiratory infections in hospitalized children treated with LGG, compared with patients who received placebo. There are also evidence which demonstrate a potential role zinc in reducing the incidence of respiratory infections is that bowel. We thought, therefore, to perform a multicenter randomized controlled trial with the aim to evaluate the role of a complex containing LGG, vitamins and zinc in the prevention of nosocomial gastrointestinal and respiratory tract infections in pediatric wards.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date June 2015
Est. primary completion date October 2014
Accepts healthy volunteers No
Gender Both
Age group 3 Months to 5 Years
Eligibility Inclusion Criteria:

- Males and females between the ages of 3 months and 5 years

- Children admitted to a pediatric ward

Exclusion Criteria:

- Children with chronic diseases of the respiratory , gastrointestinal , renal system;

- Children with malformations of the cardiovascular system ;

- Children with immune deficiencies ;

- Infants born preterm ( gestational age < 37 weeks ) ;

- Children with congenital metabolic diseases ;

- Children Who received probiotics before enrollment ( up to 7 days before hospitalization)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Lactobacillus Rhamnosus GG
1 vials q12 for 15 days
PLACEBO
1 vials q12 for 15 days

Locations

Country Name City State
Italy University of Naples "Federico II" Naples

Sponsors (1)

Lead Sponsor Collaborator
Federico II University

Country where clinical trial is conducted

Italy, 

References & Publications (7)

Brooks WA, Santosham M, Naheed A, Goswami D, Wahed MA, Diener-West M, Faruque AS, Black RE. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet. 2005 Sep 17-23;366(9490):999-1004. — View Citation

Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006 May;3(5):275-84. Review. — View Citation

Hojsak I, Abdovic S, Szajewska H, Milosevic M, Krznaric Z, Kolacek S. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 2010 May;125(5):e1171-7. doi: 10.1542/peds.2009-2568. Epub 2010 Apr 19. — View Citation

Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004 Jun;4(6):478-85. — View Citation

Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol. 2006 Nov;6(11):849-58. Epub 2006 Oct 6. Review. — View Citation

Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med. 2008 Jun;263(6):597-606. doi: 10.1111/j.1365-2796.2008.01962.x. Review. — View Citation

Sazawal S, Black RE, Bhan MK, Bhandari N, Sinha A, Jalla S. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med. 1995 Sep 28;333(13):839-44. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Study the incidence of nosocomial gastrointestinal infection After 15 days of treatment No
Primary Study the incidence of nosocomial URTI After 15 days of treatment No
Secondary Days of hospitalization After 3 months from the enrollment No
Secondary The incidence of gastrointestinal and respiratory infection during the 3 month follow-up period After 3 months from the treatment No
See also
  Status Clinical Trial Phase
Completed NCT03365635 - Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C Phase 4
Recruiting NCT05904535 - Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections
Completed NCT01704430 - Glutamine to Improve Outcomes in Cardiac Surgery N/A
Terminated NCT01225159 - Tight Glycaemic Control During Cardiac Surgery N/A
Recruiting NCT04659356 - NOSOcomial COVID-19 in ICU (NOSOCOVID)
Terminated NCT03423147 - Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor Phase 2
Completed NCT03429283 - Achromobacter Xylosoxidans (ACHX) Infections
Recruiting NCT04252651 - Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
Completed NCT04405934 - COG-UK Project Hospital-Onset COVID-19 Infections Study N/A
Active, not recruiting NCT03865706 - Inulin for Infections in the Intensive Care Unit Phase 2
Recruiting NCT05411562 - COVID-19 Genomic Sequencing for Nosocomial Outbreak Investigations
Completed NCT03250104 - Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
Completed NCT01763008 - A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections Phase 4
Completed NCT00864929 - An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice N/A
Terminated NCT01515020 - Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia Phase 3
Active, not recruiting NCT05511129 - Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU
Completed NCT04212130 - Can Environmental Cleanliness be Assessed by BCA (Bicinchoninic Acid) Method N/A
Active, not recruiting NCT05988853 - Biosafety of Musical Instruments in the ICU
Recruiting NCT01943331 - Epidemiological Investigation of CRBSI, VAP, CAUTI in Chinese ICU N/A
Completed NCT00105625 - VA Nutrition Study on Immune Function N/A